Abstract
Respiratory anthrax is a fatal disease in the absence of early therapy with antibiotics. Guinea pigs are highly sensitive to infection with Bacillus anthracis spores by intranasal spore instillation succumbing within 2 to 4 days post infection. Post exposure prophylaxis that initiated 24 h post infection with tetracycline, doxycycline, ciprofloxacin, ofloxacin, erythromycin, gentamicin or imipenem protected the animals, but after termination of treatment the animals developed a fatal anthrax disease. Combined treatment with antibiotics and active immunization with PA based vaccine conferred an efficient immune response that prevented the development of a fatal anthrax disease after termination of antibiotic administration. The CDC recommended in case of a major bioterrorist attack a mass distribution of antibiotics within 48 h. As the onset of symptoms in humans were reported to start on day 1–7 post exposure, this delay in initiation of treatment may result in treatment of sick populations. We evaluated the efficacy of late antibiotic administration starting from 30 h post infections and every 6 h thereafter, to cure respiratory anthrax sick animals. Administration of ciprofloxacin provided efficient protection up to 44 h post infection, at which time 60% of the sick animals survived. Administration of doxycycline cured up to 48 h post infection, when up to 75% of the sick animals survived. The antibiotic administration protected most animals with bacteremia level up to 105 CFU/ml, but failed to protect animals exhibiting higher levels of bacteremia. In conclusion these results demonstrate the efficacy of antibiotic treatment to cure animals even after the onset of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altboum, Z., Gozes, Y., Barnea, A., Pass, A., White, M. & Kobiler, D. (2002) Post exposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs. Infect Immun 70, 6231–41.
Friedlander, A. M., Welkos, S. L., Pitt, M. L. M., Ezzell, J. W., Worsham, P. L., Rose, K. J., Ivins, B. E., Lowe, J. R., How, G. B., Mikesell, P. & Lawrence, W. B. (1993) Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis 167, 1239–42.
Henderson, D. W., Peacock, S. & Belton, F. C. (1956) Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J Hyg 54, 28–36.
Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Friedlander, A. M., Hauer, J., Mcdade, J., Osterholm, M. T., O’toole, T., Parker, G., Perl, T. M., Russell, P. K. & Tonat, K. (1999) Anthrax as biological weapon, medical and public health management. JAMA 281, 1735–45.
Inglesby, T. V., O’toole, T., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Friedlander, A. M., Gerberding, J., Hauer, J., Hughes, J., Mcdade, J., Osterholm, M. T., Parker, G., Perl, T. M., Russell, P. K., & Tonat, K . (2002) Anthrax as a biological weapon, 2002, updated recommendations for management. JAMA 287, 2236–52.
Jernigan, J. A., Stephens, D. S., Ashford, D. A., Omenaca, C., Topiel, M. S., Galbraith, M., et al. (2001) Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerg Infect Diseases 7, 933–44.
Jones, M. N., Beedman, R. J., Turnbul, P. C. B. & Manchee, R. J. (1996) Antibiotic prophylaxis for inhalational anthrax. Salisbury Med Bull (Special Supplement) 87, 127–8.
Kobiler, D., Weiss, S., Levy, H., Fisher, M., Mechaly, A., Pass, A. & Altboum, Z. (2006) Protective antigen as a correlative marker for Anthrax in animal models. Infect Immun 74, 5871–76.
Reuveny, S., White, M. D., Adar, Y. Y., Kafri, Y., Altboum, Z., Gozes, Y., Kobiler, D., Shafferman, A. & Velan, B. (2001) Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun 69, 2888–93.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this paper
Cite this paper
Altboum, Z. et al. (2010). The Efficacy of Antibiotic Treatment to Cure Guinea Pigs Intranasally Infected with Bacillus anthracis Spores. In: Shafferman, A., Ordentlich, A., Velan, B. (eds) The Challenge of Highly Pathogenic Microorganisms. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9054-6_31
Download citation
DOI: https://doi.org/10.1007/978-90-481-9054-6_31
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9053-9
Online ISBN: 978-90-481-9054-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)